Project
avrg: Illumina Body Map 2 (GSE30611)
Navigation
Downloads
Results for ZEB1
Z-value: 6.01
Motif logo
Transcription factors associated with ZEB1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ZEB1
|
ENSG00000148516.23 | ZEB1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZEB1 | hg38_v1_chr10_+_31319125_31319227 | -0.23 | 2.0e-01 | Click! |
Activity profile of ZEB1 motif
Sorted Z-values of ZEB1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of ZEB1
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.0 | 41.7 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 4.7 | 23.4 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 4.6 | 18.3 | GO:0032599 | B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 3.9 | 27.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 3.6 | 14.4 | GO:0048627 | myoblast development(GO:0048627) |
| 3.1 | 6.2 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 2.9 | 8.8 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
| 2.7 | 18.7 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 2.6 | 7.9 | GO:0035565 | regulation of pronephros size(GO:0035565) |
| 2.6 | 7.7 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 2.5 | 7.6 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 2.4 | 12.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 2.2 | 6.6 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 2.0 | 8.1 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 2.0 | 5.9 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 1.9 | 9.4 | GO:1902896 | terminal web assembly(GO:1902896) |
| 1.8 | 5.5 | GO:0070662 | mast cell proliferation(GO:0070662) |
| 1.8 | 10.9 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 1.8 | 7.1 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 1.8 | 8.8 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 1.6 | 22.9 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.6 | 6.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 1.6 | 4.7 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 1.5 | 24.8 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 1.5 | 5.9 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
| 1.4 | 4.3 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
| 1.4 | 4.3 | GO:0031247 | actin rod assembly(GO:0031247) |
| 1.4 | 6.9 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 1.4 | 26.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 1.3 | 9.4 | GO:0032439 | endosome localization(GO:0032439) |
| 1.3 | 4.0 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 1.3 | 5.3 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 1.3 | 10.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 1.3 | 6.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 1.3 | 9.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 1.3 | 5.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 1.3 | 51.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.3 | 15.3 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 1.3 | 3.8 | GO:0060482 | lobar bronchus development(GO:0060482) |
| 1.3 | 17.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 1.2 | 3.7 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
| 1.2 | 13.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 1.2 | 3.5 | GO:1902905 | positive regulation of fibril organization(GO:1902905) |
| 1.2 | 11.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 1.1 | 1.1 | GO:1902227 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 1.1 | 3.4 | GO:0060901 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 1.1 | 12.5 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 1.1 | 3.4 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 1.1 | 7.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.1 | 13.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 1.1 | 4.3 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 1.1 | 5.4 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 1.0 | 4.2 | GO:1900229 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 1.0 | 6.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 1.0 | 4.0 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.0 | 22.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 1.0 | 16.8 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 1.0 | 2.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 1.0 | 4.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.9 | 11.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.9 | 4.6 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
| 0.9 | 13.8 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.9 | 2.7 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.9 | 2.6 | GO:0031104 | dendrite regeneration(GO:0031104) |
| 0.9 | 3.5 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.9 | 8.7 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.9 | 3.5 | GO:0035962 | response to interleukin-13(GO:0035962) |
| 0.9 | 5.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.8 | 12.6 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.8 | 5.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.8 | 5.0 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.8 | 4.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.8 | 2.5 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.8 | 3.3 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.8 | 4.9 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.8 | 2.4 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.8 | 12.8 | GO:0015871 | choline transport(GO:0015871) |
| 0.8 | 0.8 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.8 | 4.8 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.8 | 4.0 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.8 | 7.9 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.8 | 6.2 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.8 | 3.8 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.8 | 4.6 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.8 | 3.8 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.8 | 6.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.8 | 6.8 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.7 | 9.0 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.7 | 3.7 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.7 | 4.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.7 | 3.6 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.7 | 2.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.7 | 7.7 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.7 | 1.4 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
| 0.7 | 2.8 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.7 | 2.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.7 | 5.4 | GO:1903382 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.7 | 3.3 | GO:1902904 | late endosomal microautophagy(GO:0061738) negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.7 | 0.7 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.7 | 2.0 | GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
| 0.7 | 17.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.7 | 2.0 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.7 | 2.0 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.7 | 3.3 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.6 | 9.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.6 | 3.8 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.6 | 2.6 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.6 | 2.6 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 0.6 | 8.9 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.6 | 2.5 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.6 | 6.9 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.6 | 3.8 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 biosynthetic process(GO:0042819) |
| 0.6 | 2.5 | GO:0034445 | plasma lipoprotein particle oxidation(GO:0034441) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.6 | 1.9 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.6 | 0.6 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.6 | 2.5 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.6 | 6.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.6 | 3.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.6 | 4.9 | GO:0021592 | fourth ventricle development(GO:0021592) |
| 0.6 | 1.2 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.6 | 1.8 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
| 0.6 | 3.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.6 | 1.2 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.6 | 1.8 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.6 | 2.4 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.6 | 1.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.6 | 2.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.6 | 2.3 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
| 0.6 | 2.3 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.6 | 1.7 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.6 | 3.4 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.6 | 2.8 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.6 | 7.3 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.6 | 2.2 | GO:0070650 | cytoplasmic actin-based contraction involved in cell motility(GO:0060327) endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 0.6 | 1.7 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.6 | 2.8 | GO:0055062 | phosphate ion homeostasis(GO:0055062) trivalent inorganic anion homeostasis(GO:0072506) |
| 0.5 | 2.2 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
| 0.5 | 3.8 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.5 | 6.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.5 | 2.2 | GO:0042223 | response to molecule of fungal origin(GO:0002238) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) positive regulation of gamma-delta T cell differentiation(GO:0045588) cellular response to molecule of fungal origin(GO:0071226) |
| 0.5 | 6.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.5 | 5.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.5 | 3.1 | GO:0006524 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.5 | 0.5 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 0.5 | 2.0 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.5 | 1.5 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.5 | 2.0 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.5 | 4.4 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.5 | 1.5 | GO:0061182 | negative regulation of chondrocyte development(GO:0061182) |
| 0.5 | 11.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.5 | 49.0 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 0.5 | 7.2 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.5 | 1.9 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
| 0.5 | 2.3 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 0.5 | 3.6 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.5 | 1.8 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.5 | 0.9 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.4 | 2.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.4 | 1.3 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 0.4 | 2.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.4 | 9.2 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
| 0.4 | 1.8 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.4 | 0.4 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.4 | 2.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.4 | 3.0 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.4 | 6.4 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.4 | 0.8 | GO:0009822 | alkaloid catabolic process(GO:0009822) monoterpenoid metabolic process(GO:0016098) |
| 0.4 | 2.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.4 | 0.8 | GO:0014806 | smooth muscle hyperplasia(GO:0014806) |
| 0.4 | 7.4 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.4 | 10.5 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.4 | 1.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.4 | 2.4 | GO:0070378 | positive regulation of ERK5 cascade(GO:0070378) |
| 0.4 | 2.8 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.4 | 1.6 | GO:0048749 | compound eye development(GO:0048749) |
| 0.4 | 1.2 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.4 | 2.0 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.4 | 2.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.4 | 1.9 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.4 | 1.2 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.4 | 0.8 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.4 | 5.4 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.4 | 0.8 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
| 0.4 | 1.5 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.4 | 7.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.4 | 1.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
| 0.4 | 2.3 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.4 | 1.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.4 | 3.0 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.4 | 1.5 | GO:1903610 | regulation of calcium-dependent ATPase activity(GO:1903610) negative regulation of calcium-dependent ATPase activity(GO:1903611) regulation of dUTP diphosphatase activity(GO:1903627) positive regulation of dUTP diphosphatase activity(GO:1903629) negative regulation of aminoacyl-tRNA ligase activity(GO:1903631) regulation of leucine-tRNA ligase activity(GO:1903633) negative regulation of leucine-tRNA ligase activity(GO:1903634) |
| 0.4 | 6.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.4 | 1.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.4 | 2.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.4 | 1.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.4 | 0.4 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 0.4 | 8.8 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.4 | 3.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.4 | 1.1 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.4 | 7.9 | GO:0070831 | basement membrane assembly(GO:0070831) |
| 0.4 | 1.4 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.4 | 9.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.4 | 3.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.4 | 1.1 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.4 | 1.8 | GO:0033383 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.4 | 1.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.4 | 2.1 | GO:0019050 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) |
| 0.4 | 1.8 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.4 | 23.1 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.3 | 1.7 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.3 | 2.1 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
| 0.3 | 4.2 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.3 | 2.4 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.3 | 2.4 | GO:0031438 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.3 | 4.1 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.3 | 10.8 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.3 | 1.0 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.3 | 2.0 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.3 | 7.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.3 | 50.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.3 | 2.3 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.3 | 1.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.3 | 2.0 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.3 | 1.6 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.3 | 7.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.3 | 1.0 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.3 | 2.9 | GO:0015705 | iodide transport(GO:0015705) |
| 0.3 | 1.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.3 | 18.5 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.3 | 1.2 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.3 | 0.3 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.3 | 5.9 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.3 | 0.9 | GO:2001311 | lysobisphosphatidic acid metabolic process(GO:2001311) |
| 0.3 | 1.5 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.3 | 2.1 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.3 | 0.9 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.3 | 0.9 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.3 | 6.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.3 | 0.9 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.3 | 1.5 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.3 | 1.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
| 0.3 | 2.7 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.3 | 7.7 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.3 | 1.5 | GO:0030070 | insulin processing(GO:0030070) |
| 0.3 | 0.9 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.3 | 0.9 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.3 | 3.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.3 | 2.6 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.3 | 0.3 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
| 0.3 | 6.3 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
| 0.3 | 3.4 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.3 | 1.1 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.3 | 1.7 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.3 | 3.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.3 | 9.8 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.3 | 0.8 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.3 | 1.1 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.3 | 1.6 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.3 | 3.0 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.3 | 0.8 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.3 | 0.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.3 | 2.1 | GO:0015884 | folic acid transport(GO:0015884) |
| 0.3 | 3.7 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.3 | 3.5 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.3 | 0.8 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.3 | 4.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.3 | 0.8 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.3 | 0.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.3 | 1.0 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.3 | 0.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.3 | 0.5 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.3 | 1.8 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.3 | 1.5 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.3 | 1.3 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.3 | 1.5 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
| 0.3 | 0.5 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.3 | 4.5 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.3 | 1.3 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.3 | 3.8 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.3 | 0.5 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 0.2 | 10.0 | GO:0015893 | drug transport(GO:0015893) |
| 0.2 | 23.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.2 | 6.6 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.2 | 19.5 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
| 0.2 | 5.6 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.2 | 2.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.2 | 1.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.2 | 5.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.2 | 0.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.2 | 1.0 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.2 | 1.2 | GO:0061364 | response to cortisol(GO:0051414) apoptotic process involved in luteolysis(GO:0061364) |
| 0.2 | 1.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.2 | 0.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.2 | 0.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.2 | 5.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 | 0.7 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.2 | 1.4 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.2 | 0.9 | GO:0009305 | protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
| 0.2 | 1.6 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 | 0.5 | GO:1902338 | negative regulation of apoptotic process involved in morphogenesis(GO:1902338) negative regulation of apoptotic process involved in development(GO:1904746) |
| 0.2 | 1.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.2 | 0.9 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.2 | 1.1 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.2 | 0.7 | GO:0035732 | nitric oxide storage(GO:0035732) |
| 0.2 | 2.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.2 | 1.4 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.2 | 0.7 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
| 0.2 | 0.7 | GO:1902568 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.2 | 0.9 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.2 | 2.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.2 | 0.7 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 | 0.7 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.2 | 0.7 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 0.2 | 0.4 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.2 | 2.4 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.2 | 2.6 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.2 | 0.9 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.2 | 0.2 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.2 | 1.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.2 | 1.0 | GO:0051715 | cytolysis in other organism(GO:0051715) |
| 0.2 | 1.3 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.2 | 0.8 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.2 | 0.4 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.2 | 0.2 | GO:1904782 | negative regulation of glutamate receptor signaling pathway(GO:1900450) negative regulation of NMDA glutamate receptor activity(GO:1904782) |
| 0.2 | 0.6 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.2 | 2.5 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 0.2 | 0.4 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
| 0.2 | 1.0 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 | 5.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.2 | 0.4 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.2 | 3.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.2 | 2.4 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.2 | 0.6 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
| 0.2 | 0.8 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 0.2 | 4.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.2 | 1.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.2 | 0.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.2 | 3.3 | GO:0015684 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
| 0.2 | 0.6 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.2 | 3.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.2 | 1.3 | GO:0060023 | soft palate development(GO:0060023) |
| 0.2 | 0.6 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.2 | 0.6 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.2 | 2.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.2 | 2.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.2 | 0.8 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.2 | 2.0 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.2 | 14.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
| 0.2 | 0.7 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.2 | 0.4 | GO:0042335 | cuticle development(GO:0042335) |
| 0.2 | 0.4 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.2 | 0.9 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.2 | 1.1 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 0.2 | 0.2 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.2 | 1.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.2 | 0.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.2 | 8.1 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.2 | 3.1 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.2 | 23.3 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
| 0.2 | 1.6 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.2 | 0.5 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.2 | 1.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.2 | 6.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
| 0.2 | 0.7 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) |
| 0.2 | 2.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.2 | 2.8 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.2 | 7.9 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.2 | 1.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.2 | 2.4 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
| 0.2 | 2.4 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.2 | 2.5 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.2 | 2.7 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
| 0.2 | 2.2 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.2 | 1.2 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.2 | 3.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.2 | 0.3 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 0.2 | 2.5 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.2 | 0.7 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 0.2 | 1.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.2 | 1.0 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.2 | 0.5 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
| 0.2 | 2.4 | GO:0000050 | urea cycle(GO:0000050) |
| 0.2 | 1.0 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 0.2 | 1.0 | GO:0007350 | blastoderm segmentation(GO:0007350) |
| 0.2 | 0.6 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.2 | 0.8 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.2 | 1.6 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 | 1.6 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.2 | 0.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.2 | 1.7 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.2 | 2.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 | 0.6 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.2 | 1.1 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.2 | 0.5 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.2 | 0.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
| 0.2 | 3.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.2 | 0.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.2 | 4.2 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.2 | 0.5 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.2 | 1.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 1.3 | GO:0097205 | renal filtration(GO:0097205) |
| 0.1 | 0.4 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.1 | 2.9 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.1 | 1.5 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.1 | 0.6 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.1 | 1.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
| 0.1 | 1.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 | 1.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.1 | 0.6 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.1 | 0.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 | 2.1 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 | 0.4 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 | 0.9 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 0.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.1 | 0.3 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.1 | 0.6 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.1 | 0.4 | GO:1903778 | positive regulation of histamine secretion by mast cell(GO:1903595) protein localization to vacuolar membrane(GO:1903778) |
| 0.1 | 1.4 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.1 | 1.9 | GO:0009629 | response to gravity(GO:0009629) |
| 0.1 | 20.0 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
| 0.1 | 0.4 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 | 0.4 | GO:0010820 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
| 0.1 | 1.1 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.1 | 6.3 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.1 | 2.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 3.5 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 2.5 | GO:0043586 | tongue development(GO:0043586) |
| 0.1 | 0.4 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.1 | 0.4 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.1 | 1.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 | 1.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.1 | 0.4 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.1 | 0.9 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 | 0.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 0.1 | 2.7 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.1 | 1.6 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 | 16.7 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 2.4 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.1 | 1.9 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.1 | 3.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 | 1.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.1 | 0.5 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 | 0.2 | GO:1902724 | positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 0.1 | 0.5 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.1 | 0.9 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.1 | 2.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.1 | 0.2 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 0.1 | 1.9 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 | 1.0 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
| 0.1 | 1.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.1 | 1.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.1 | 1.4 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.1 | 0.6 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.1 | 0.4 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.1 | 1.2 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 | 4.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 | 1.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 | 0.8 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.1 | 3.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 | 0.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 | 0.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 | 0.7 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.1 | 0.3 | GO:0022605 | oogenesis stage(GO:0022605) |
| 0.1 | 3.1 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.1 | 0.5 | GO:0021678 | third ventricle development(GO:0021678) |
| 0.1 | 1.0 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.1 | 1.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.1 | 1.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 | 0.3 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
| 0.1 | 1.0 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.1 | 0.6 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 | 0.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.1 | 9.9 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 1.0 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.1 | 2.9 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.1 | 2.3 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.1 | 0.4 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.1 | 0.4 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 0.1 | 1.1 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
| 0.1 | 0.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.1 | 0.2 | GO:1902232 | regulation of positive thymic T cell selection(GO:1902232) |
| 0.1 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 | 0.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 | 1.5 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 | 1.9 | GO:0006555 | methionine metabolic process(GO:0006555) |
| 0.1 | 0.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 | 0.4 | GO:0006562 | proline catabolic process(GO:0006562) |
| 0.1 | 2.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 | 0.4 | GO:1903567 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.1 | 1.0 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.1 | 1.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 | 0.7 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.1 | 0.9 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 | 0.5 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.1 | 0.6 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
| 0.1 | 0.3 | GO:0010266 | response to vitamin B1(GO:0010266) |
| 0.1 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 0.4 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.1 | 0.5 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
| 0.1 | 0.7 | GO:0002385 | mucosal immune response(GO:0002385) |
| 0.1 | 0.7 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 | 1.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 2.1 | GO:0015816 | glycine transport(GO:0015816) |
| 0.1 | 1.4 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
| 0.1 | 3.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 2.1 | GO:0097034 | mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 | 0.2 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 0.1 | 1.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 | 1.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 | 0.7 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.1 | 0.7 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.1 | 0.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.1 | 0.4 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.1 | 1.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.1 | 0.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 | 1.6 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.1 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.1 | 1.8 | GO:0036065 | fucosylation(GO:0036065) |
| 0.1 | 0.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 0.3 | GO:0048793 | pronephros development(GO:0048793) |
| 0.1 | 0.5 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.1 | 2.0 | GO:0002360 | T cell lineage commitment(GO:0002360) |
| 0.1 | 0.8 | GO:0043297 | apical junction assembly(GO:0043297) |
| 0.1 | 0.4 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.1 | 0.7 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
| 0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 0.4 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.1 | 1.8 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 | 1.7 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.1 | 3.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.1 | 1.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.1 | 1.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.1 | 0.9 | GO:0001553 | luteinization(GO:0001553) |
| 0.1 | 2.0 | GO:0060972 | left/right pattern formation(GO:0060972) |
| 0.1 | 3.6 | GO:0050918 | positive chemotaxis(GO:0050918) |
| 0.1 | 1.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.1 | 0.3 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.1 | 1.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.1 | 1.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.1 | 0.5 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 | 0.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.1 | 0.8 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.1 | 0.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 | 0.9 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 0.2 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 0.1 | 1.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 | 0.7 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 | 0.7 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.1 | 0.5 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.1 | 0.5 | GO:0060356 | leucine import(GO:0060356) |
| 0.1 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 | 1.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 | 0.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.1 | 1.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.1 | 2.5 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 | 0.6 | GO:0050955 | thermoception(GO:0050955) |
| 0.1 | 0.9 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
| 0.1 | 0.6 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 0.4 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 | 0.8 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 | 0.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 | 0.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.1 | 1.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 | 0.8 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
| 0.1 | 0.2 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
| 0.1 | 0.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 2.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 | 0.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 | 1.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 | 0.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 | 2.0 | GO:0042026 | protein refolding(GO:0042026) |
| 0.1 | 1.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 | 0.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.1 | 0.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.1 | 0.1 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
| 0.1 | 0.2 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.1 | 0.3 | GO:0001845 | phagolysosome assembly(GO:0001845) |
| 0.1 | 0.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.1 | 0.3 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 | 0.4 | GO:0042045 | epithelial fluid transport(GO:0042045) |
| 0.1 | 0.5 | GO:2000194 | regulation of female gonad development(GO:2000194) |
| 0.1 | 1.3 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 | 0.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.1 | 0.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 | 0.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.1 | 1.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 0.7 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.1 | 0.6 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.1 | 0.2 | GO:0030200 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 | 1.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 | 0.5 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.1 | 1.1 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
| 0.1 | 0.7 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
| 0.1 | 0.2 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.1 | 1.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.1 | 0.6 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 | 0.2 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
| 0.1 | 1.0 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.1 | 1.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.1 | 0.7 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.1 | 0.4 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 | 0.5 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.1 | 0.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.1 | 0.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 | 0.5 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.1 | 1.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 | 0.4 | GO:0060613 | fat pad development(GO:0060613) |
| 0.1 | 1.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.1 | 0.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 | 0.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
| 0.1 | 5.6 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
| 0.1 | 1.5 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 | 0.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.1 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 | 0.2 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.1 | 0.6 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 | 0.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 | 0.5 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 0.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
| 0.0 | 3.1 | GO:0046849 | bone remodeling(GO:0046849) |
| 0.0 | 0.7 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.0 | 0.1 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.0 | 0.5 | GO:0008050 | female courtship behavior(GO:0008050) |
| 0.0 | 0.2 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.0 | 0.3 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.0 | 0.7 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.0 | 6.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.0 | 0.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.0 | 1.2 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.0 | 0.0 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.0 | 0.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.0 | 0.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.0 | 0.4 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
| 0.0 | 2.6 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
| 0.0 | 3.4 | GO:0007032 | endosome organization(GO:0007032) |
| 0.0 | 1.0 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 | 0.2 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.0 | 1.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.0 | 0.2 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
| 0.0 | 0.4 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.0 | 2.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 | 1.1 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.0 | 0.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.0 | 0.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 | 0.5 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.0 | 0.5 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
| 0.0 | 0.2 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.0 | 0.0 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.0 | 0.1 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 0.0 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.0 | 1.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.0 | 1.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 | 0.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
| 0.0 | 0.6 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.0 | 0.3 | GO:0030903 | notochord development(GO:0030903) |
| 0.0 | 0.2 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 | 0.7 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.0 | 0.2 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.0 | 0.2 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
| 0.0 | 0.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.0 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.0 | 1.7 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
| 0.0 | 0.1 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
| 0.0 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.0 | 0.8 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
| 0.0 | 1.1 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.0 | 1.9 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.0 | 0.5 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
| 0.0 | 0.4 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.0 | 0.2 | GO:0046060 | dATP metabolic process(GO:0046060) |
| 0.0 | 0.5 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.0 | 0.6 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
| 0.0 | 0.8 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
| 0.0 | 0.3 | GO:0001569 | patterning of blood vessels(GO:0001569) |
| 0.0 | 0.5 | GO:0080111 | DNA demethylation(GO:0080111) |
| 0.0 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.0 | 0.1 | GO:0036245 | cellular response to menadione(GO:0036245) |
| 0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.0 | 1.1 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.0 | 0.3 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.0 | 0.1 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.0 | 1.7 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.0 | 0.6 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.0 | 0.1 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
| 0.0 | 0.1 | GO:0043465 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 0.0 | 0.1 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.0 | 0.3 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.0 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
| 0.0 | 0.3 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.0 | 0.6 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.0 | 0.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.0 | 0.8 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
| 0.0 | 3.3 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.0 | 1.0 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.0 | 0.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 | 0.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.0 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 0.0 | 1.2 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 | 0.4 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
| 0.0 | 1.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 0.4 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.0 | 0.1 | GO:0072143 | renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.0 | 0.4 | GO:1902001 | fatty acid transmembrane transport(GO:1902001) |
| 0.0 | 0.1 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.0 | 0.4 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.0 | 5.8 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
| 0.0 | 0.1 | GO:2000983 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.0 | 0.1 | GO:0016108 | tetraterpenoid metabolic process(GO:0016108) carotenoid metabolic process(GO:0016116) carotene catabolic process(GO:0016121) xanthophyll metabolic process(GO:0016122) terpene catabolic process(GO:0046247) |
| 0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.0 | 0.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.0 | 0.1 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.0 | 0.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 | 0.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.0 | 0.1 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.0 | 0.2 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.0 | 0.3 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
| 0.0 | 0.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.0 | 0.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.0 | 0.2 | GO:0072311 | glomerular epithelial cell differentiation(GO:0072311) |
| 0.0 | 0.4 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.0 | 2.2 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
| 0.0 | 0.1 | GO:0046101 | adenosine catabolic process(GO:0006154) hypoxanthine salvage(GO:0043103) hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
| 0.0 | 3.6 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
| 0.0 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.0 | 0.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.0 | 0.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 | 0.3 | GO:0043276 | anoikis(GO:0043276) |
| 0.0 | 0.1 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
| 0.0 | 0.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.0 | 0.2 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.0 | 0.1 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
| 0.0 | 0.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 | 0.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.0 | 0.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.0 | 0.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 | 0.0 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.0 | 2.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.0 | 0.9 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
| 0.0 | 0.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.0 | 0.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
| 0.0 | 0.3 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
| 0.0 | 0.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 1.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 | 0.0 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.0 | 0.1 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.0 | 0.3 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.0 | 0.4 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.0 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
| 0.0 | 0.0 | GO:0031000 | response to caffeine(GO:0031000) |
| 0.0 | 0.1 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.0 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.5 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 | 0.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 | 1.0 | GO:0006400 | tRNA modification(GO:0006400) |
| 0.0 | 0.0 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.0 | 0.1 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.0 | 0.0 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.0 | 0.5 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
| 0.0 | 0.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.0 | 0.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.0 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.0 | 0.1 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.0 | 0.7 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.0 | 0.1 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.0 | 0.4 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
| 0.0 | 0.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.0 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 | 1.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.0 | 0.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.0 | 0.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.6 | 47.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 3.2 | 18.9 | GO:1990357 | terminal web(GO:1990357) |
| 2.1 | 84.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 2.0 | 2.0 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 1.8 | 12.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 1.1 | 7.5 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.9 | 29.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.9 | 7.5 | GO:0070695 | FHF complex(GO:0070695) |
| 0.9 | 1.8 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.8 | 4.1 | GO:0071756 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
| 0.7 | 3.7 | GO:1990742 | microvesicle(GO:1990742) |
| 0.7 | 5.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 0.7 | 14.5 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.7 | 4.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.7 | 10.5 | GO:0043256 | laminin complex(GO:0043256) |
| 0.7 | 2.7 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.6 | 12.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.6 | 3.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.6 | 12.7 | GO:0045179 | apical cortex(GO:0045179) |
| 0.6 | 3.6 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 0.6 | 3.0 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.6 | 11.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
| 0.6 | 2.2 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.6 | 3.9 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.5 | 2.7 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.5 | 9.7 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.5 | 1.4 | GO:0097409 | glial cytoplasmic inclusion(GO:0097409) classical Lewy body(GO:0097414) Lewy neurite(GO:0097462) Lewy body corona(GO:1990038) |
| 0.5 | 5.9 | GO:0097449 | astrocyte projection(GO:0097449) |
| 0.4 | 1.3 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.4 | 15.7 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.4 | 1.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.4 | 16.2 | GO:0030057 | desmosome(GO:0030057) |
| 0.4 | 15.6 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.4 | 3.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.4 | 2.0 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.4 | 4.4 | GO:0097413 | Lewy body(GO:0097413) |
| 0.4 | 1.6 | GO:0070701 | mucus layer(GO:0070701) |
| 0.4 | 1.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.4 | 2.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.4 | 1.2 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.4 | 0.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.4 | 3.3 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.4 | 0.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.4 | 29.6 | GO:0045095 | keratin filament(GO:0045095) |
| 0.4 | 3.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.4 | 12.4 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.3 | 3.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.3 | 10.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.3 | 1.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.3 | 3.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.3 | 4.9 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
| 0.3 | 2.9 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.3 | 4.1 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.3 | 1.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.3 | 4.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.3 | 0.9 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.3 | 9.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.3 | 29.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.3 | 1.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.3 | 1.8 | GO:0032449 | CBM complex(GO:0032449) |
| 0.3 | 6.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.3 | 0.9 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.3 | 4.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.3 | 1.9 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.3 | 5.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.3 | 3.8 | GO:0097486 | alveolar lamellar body(GO:0097208) multivesicular body lumen(GO:0097486) |
| 0.3 | 0.5 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
| 0.3 | 2.4 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.3 | 1.3 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.3 | 0.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.3 | 62.4 | GO:0005923 | bicellular tight junction(GO:0005923) |
| 0.3 | 24.5 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.3 | 2.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.3 | 35.8 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.3 | 1.6 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.3 | 4.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.3 | 0.8 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.2 | 5.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.2 | 4.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.2 | 54.3 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.2 | 2.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.2 | 2.3 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.2 | 1.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.2 | 2.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.2 | 8.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.2 | 4.5 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.2 | 0.7 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.2 | 2.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.2 | 1.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.2 | 11.5 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
| 0.2 | 0.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.2 | 1.9 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.2 | 21.8 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.2 | 2.7 | GO:0045180 | basal cortex(GO:0045180) |
| 0.2 | 1.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.2 | 1.0 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.2 | 0.6 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.2 | 2.0 | GO:0032009 | early phagosome(GO:0032009) |
| 0.2 | 6.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.2 | 15.7 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.2 | 1.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.2 | 1.3 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.2 | 22.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.2 | 0.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.2 | 0.5 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.2 | 1.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.2 | 8.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.2 | 5.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.2 | 0.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.2 | 1.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.2 | 3.0 | GO:0097433 | dense body(GO:0097433) |
| 0.2 | 1.7 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.2 | 16.8 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.2 | 1.4 | GO:0098536 | deuterosome(GO:0098536) |
| 0.1 | 0.6 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.1 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 3.4 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 0.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.1 | 1.3 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 1.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.1 | 1.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.1 | 11.5 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 1.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 5.3 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.1 | 0.8 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.1 | 0.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 0.4 | GO:0005592 | collagen type XI trimer(GO:0005592) |
| 0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.1 | 0.9 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.1 | 0.4 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.1 | 0.8 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.1 | 0.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.1 | 0.6 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.1 | 0.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 5.4 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.1 | 0.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.1 | 2.6 | GO:0005922 | connexon complex(GO:0005922) |
| 0.1 | 0.3 | GO:0002140 | stereocilia tip link(GO:0002140) myosin VII complex(GO:0031477) stereocilia tip-link density(GO:1990427) upper tip-link density(GO:1990435) |
| 0.1 | 0.7 | GO:0043219 | lateral loop(GO:0043219) |
| 0.1 | 0.8 | GO:0089701 | U2AF(GO:0089701) |
| 0.1 | 3.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.1 | 0.8 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.1 | 11.8 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.1 | 1.1 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.1 | 0.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.1 | 0.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.1 | 13.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 0.8 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.1 | 38.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.1 | 0.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 2.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 4.8 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 1.0 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
| 0.1 | 1.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 0.5 | GO:0071149 | TEAD-1-YAP complex(GO:0071148) TEAD-2-YAP complex(GO:0071149) |
| 0.1 | 0.5 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 1.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 0.6 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.1 | 1.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 1.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 3.3 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 3.4 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 4.5 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 4.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.1 | 0.3 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.1 | 0.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.1 | 1.8 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 317.1 | GO:0070062 | extracellular exosome(GO:0070062) |
| 0.1 | 1.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.1 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.1 | 4.6 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 0.3 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 0.1 | 0.4 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.1 | 5.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 3.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.6 | GO:0000796 | condensin complex(GO:0000796) |
| 0.1 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.1 | 3.4 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.0 | 0.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.0 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.0 | 6.9 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.0 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.0 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.0 | 2.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.0 | 0.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.0 | 0.9 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.0 | 0.2 | GO:0097545 | axonemal outer doublet(GO:0097545) |
| 0.0 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.0 | 0.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 1.9 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.0 | 0.2 | GO:0000243 | commitment complex(GO:0000243) |
| 0.0 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.0 | 1.3 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.0 | 1.0 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 3.2 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.0 | 8.0 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.0 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.0 | 2.2 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.0 | 1.9 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 2.3 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.0 | 0.8 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.0 | 0.1 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.0 | 2.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.0 | 1.5 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.0 | 0.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.0 | 0.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.0 | 2.3 | GO:0005770 | late endosome(GO:0005770) |
| 0.0 | 0.4 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.0 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 0.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.0 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
| 0.0 | 0.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.0 | 0.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.0 | 0.1 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.0 | 27.7 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 17.5 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.0 | 0.4 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.0 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 0.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.0 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
| 0.0 | 18.5 | GO:0005576 | extracellular region(GO:0005576) |
| 0.0 | 0.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.0 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.0 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
| 0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.2 | 9.5 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 2.6 | 10.2 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 2.0 | 8.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 1.9 | 17.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 1.8 | 7.1 | GO:0004605 | diacylglycerol cholinephosphotransferase activity(GO:0004142) phosphatidate cytidylyltransferase activity(GO:0004605) |
| 1.7 | 13.6 | GO:1990254 | keratin filament binding(GO:1990254) |
| 1.7 | 5.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 1.7 | 5.1 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 1.7 | 10.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 1.6 | 6.6 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 1.6 | 4.7 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
| 1.6 | 6.2 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 1.5 | 4.6 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 1.4 | 5.7 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 1.3 | 23.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 1.2 | 3.7 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
| 1.2 | 3.7 | GO:0019785 | ISG15-specific protease activity(GO:0019785) |
| 1.2 | 5.9 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 1.1 | 10.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 1.1 | 8.7 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 1.1 | 4.3 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 1.1 | 3.2 | GO:1902098 | calcitriol receptor activity(GO:0008434) lithocholic acid receptor activity(GO:0038186) calcitriol binding(GO:1902098) lithocholic acid binding(GO:1902121) |
| 1.1 | 21.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 1.0 | 6.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 1.0 | 3.9 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 1.0 | 2.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.9 | 3.7 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
| 0.9 | 2.8 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 0.9 | 4.7 | GO:0070905 | serine binding(GO:0070905) |
| 0.9 | 7.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.9 | 2.7 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.9 | 8.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.9 | 3.6 | GO:0061609 | fructose-1-phosphate aldolase activity(GO:0061609) |
| 0.9 | 2.6 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
| 0.9 | 2.6 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.8 | 0.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.8 | 2.5 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.8 | 2.5 | GO:0052854 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
| 0.8 | 4.1 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.8 | 3.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.8 | 3.2 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.8 | 29.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.8 | 3.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.8 | 11.6 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.8 | 4.5 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.8 | 4.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 0.8 | 3.0 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.7 | 20.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.7 | 3.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.7 | 5.0 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.7 | 2.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 0.7 | 2.1 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.7 | 2.7 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
| 0.7 | 2.0 | GO:0005139 | interleukin-7 receptor binding(GO:0005139) |
| 0.7 | 2.0 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
| 0.7 | 5.3 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.7 | 10.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.7 | 11.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.7 | 4.6 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.6 | 27.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.6 | 32.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.6 | 3.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.6 | 4.1 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.6 | 7.1 | GO:0019864 | IgG binding(GO:0019864) |
| 0.6 | 1.8 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.6 | 1.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.6 | 1.7 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 0.6 | 1.7 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 0.5 | 2.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.5 | 17.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.5 | 1.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.5 | 4.3 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.5 | 18.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.5 | 4.7 | GO:0005497 | androgen binding(GO:0005497) |
| 0.5 | 2.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.5 | 6.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.5 | 3.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.5 | 4.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.5 | 2.0 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.5 | 10.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.5 | 1.5 | GO:0042007 | interleukin-18 binding(GO:0042007) |
| 0.5 | 1.4 | GO:0008903 | hydroxypyruvate isomerase activity(GO:0008903) |
| 0.5 | 6.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.5 | 1.4 | GO:0072545 | tyrosine binding(GO:0072545) |
| 0.5 | 14.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.5 | 22.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.5 | 1.4 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
| 0.5 | 1.8 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.4 | 1.3 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.4 | 4.9 | GO:0071253 | connexin binding(GO:0071253) |
| 0.4 | 2.2 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.4 | 1.3 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.4 | 4.4 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
| 0.4 | 2.2 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.4 | 1.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.4 | 1.7 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
| 0.4 | 2.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.4 | 7.4 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.4 | 2.0 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.4 | 7.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.4 | 0.8 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
| 0.4 | 13.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.4 | 1.2 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
| 0.4 | 1.5 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.4 | 5.4 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.4 | 1.1 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 0.4 | 1.9 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.4 | 1.5 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 0.4 | 1.1 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.4 | 1.5 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.4 | 3.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.4 | 4.3 | GO:0046790 | virion binding(GO:0046790) |
| 0.4 | 1.8 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.4 | 2.8 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.4 | 16.7 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.4 | 6.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.4 | 1.8 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.3 | 2.1 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.3 | 56.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.3 | 4.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.3 | 3.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.3 | 2.7 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.3 | 8.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.3 | 2.7 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.3 | 1.3 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.3 | 5.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.3 | 3.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.3 | 5.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.3 | 2.6 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.3 | 1.9 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.3 | 1.0 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 0.3 | 3.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.3 | 21.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.3 | 0.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.3 | 1.3 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.3 | 6.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.3 | 1.2 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.3 | 0.9 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.3 | 1.2 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.3 | 7.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.3 | 2.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.3 | 2.4 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.3 | 0.9 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.3 | 2.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.3 | 3.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.3 | 4.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.3 | 0.8 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 0.3 | 0.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.3 | 1.1 | GO:0002046 | opsin binding(GO:0002046) |
| 0.3 | 1.1 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.3 | 0.8 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.3 | 2.2 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.3 | 1.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.3 | 2.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.3 | 1.3 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 0.3 | 4.3 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.3 | 4.8 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.3 | 3.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.3 | 3.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.3 | 2.8 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.2 | 2.5 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.2 | 1.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.2 | 0.7 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.2 | 66.5 | GO:0003823 | antigen binding(GO:0003823) |
| 0.2 | 1.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.2 | 0.7 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.2 | 0.7 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
| 0.2 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.2 | 1.2 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) |
| 0.2 | 0.7 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.2 | 0.9 | GO:0004078 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
| 0.2 | 2.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.2 | 1.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.2 | 3.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.2 | 3.0 | GO:0050544 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
| 0.2 | 1.1 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.2 | 8.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.2 | 3.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.2 | 4.7 | GO:0070513 | death domain binding(GO:0070513) |
| 0.2 | 1.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.2 | 2.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.2 | 0.9 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.2 | 22.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.2 | 4.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.2 | 0.9 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.2 | 5.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.2 | 1.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.2 | 2.9 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.2 | 1.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.2 | 6.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
| 0.2 | 1.4 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.2 | 1.0 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.2 | 2.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.2 | 3.5 | GO:0019841 | retinol binding(GO:0019841) |
| 0.2 | 4.1 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.2 | 2.2 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
| 0.2 | 1.2 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.2 | 1.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.2 | 3.6 | GO:0008430 | selenium binding(GO:0008430) |
| 0.2 | 0.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.2 | 5.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.2 | 1.0 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.2 | 8.1 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.2 | 2.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.2 | 0.6 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.2 | 13.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.2 | 1.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.2 | 0.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.2 | 3.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.2 | 1.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.2 | 0.9 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.2 | 0.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.2 | 1.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.2 | 2.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.2 | 2.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.2 | 8.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.2 | 2.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.2 | 0.7 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.2 | 5.6 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.2 | 0.7 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
| 0.2 | 0.9 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
| 0.2 | 1.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.2 | 1.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.2 | 16.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.2 | 1.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.2 | 1.9 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.2 | 0.5 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.2 | 1.3 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.2 | 0.5 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.2 | 0.5 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.2 | 3.3 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.2 | 0.5 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.2 | 10.2 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.2 | 19.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.2 | 0.8 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.2 | 0.5 | GO:0036326 | VEGF-A-activated receptor activity(GO:0036326) VEGF-B-activated receptor activity(GO:0036327) placental growth factor-activated receptor activity(GO:0036332) |
| 0.2 | 3.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.2 | 5.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
| 0.2 | 0.6 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.2 | 1.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.2 | 0.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.2 | 1.5 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.2 | 6.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.2 | 4.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.2 | 1.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.2 | 0.9 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.2 | 1.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.2 | 0.6 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.2 | 1.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.2 | 0.5 | GO:0051990 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.1 | 1.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.1 | 1.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.1 | 4.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 6.0 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.1 | 5.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.1 | 2.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.1 | 3.8 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 4.6 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 3.9 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 4.7 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
| 0.1 | 17.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 2.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 4.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.1 | 0.7 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.1 | 0.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.1 | 0.4 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 0.1 | 30.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 0.4 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 0.1 | 2.2 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.1 | 1.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.1 | 0.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 0.9 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.1 | 1.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.1 | 3.7 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 0.5 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 0.1 | 2.0 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
| 0.1 | 1.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.1 | 2.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 0.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.1 | 3.8 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.1 | 3.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 0.8 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.1 | 1.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.1 | 0.5 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
| 0.1 | 0.7 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.1 | 3.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.1 | 2.7 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.1 | 0.3 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.1 | 1.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 0.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.1 | 1.3 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.1 | 2.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 2.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 0.9 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 0.1 | 0.8 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.1 | 0.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.1 | 4.9 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 0.5 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.1 | 0.5 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.1 | 1.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.1 | 2.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.1 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
| 0.1 | 0.4 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 0.1 | 0.4 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
| 0.1 | 3.6 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 0.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.1 | 0.9 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.1 | 0.9 | GO:0043426 | MRF binding(GO:0043426) |
| 0.1 | 0.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.1 | 1.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.1 | 0.5 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.1 | 0.2 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.1 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.1 | 2.2 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.1 | 2.0 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.1 | 1.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.1 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.1 | 0.6 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.1 | 4.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.1 | 4.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 3.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
| 0.1 | 0.7 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.1 | 4.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 1.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 1.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
| 0.1 | 0.6 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.1 | 1.2 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.1 | 1.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.1 | 7.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.1 | 0.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.1 | 1.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.1 | 1.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 0.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.1 | 0.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.1 | 0.3 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.1 | 3.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.1 | 0.3 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.1 | 1.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 1.3 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 0.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.1 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.1 | 1.0 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.1 | 0.2 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.1 | 1.9 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.1 | 2.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 2.5 | GO:0001848 | complement binding(GO:0001848) |
| 0.1 | 1.1 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.1 | 1.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.1 | 1.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.1 | 1.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.1 | 0.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
| 0.1 | 0.5 | GO:0045174 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.1 | 1.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.1 | 1.0 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 0.9 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.1 | 1.1 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.1 | 1.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 1.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.1 | 0.3 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.1 | 0.4 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.1 | 1.6 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.1 | 1.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.1 | 0.2 | GO:0033842 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity(GO:0033842) |
| 0.1 | 2.3 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 0.6 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.1 | 1.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 4.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.1 | 1.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 0.2 | GO:0031177 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) phosphopantetheine binding(GO:0031177) |
| 0.1 | 18.2 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.1 | 0.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
| 0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.1 | 0.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.1 | 0.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.1 | 0.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.1 | 0.4 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.1 | 6.0 | GO:0005496 | steroid binding(GO:0005496) |
| 0.1 | 1.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.1 | 0.7 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.1 | 0.2 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
| 0.1 | 0.8 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 0.2 | GO:0032560 | dGTPase activity(GO:0008832) triphosphoric monoester hydrolase activity(GO:0016793) guanyl deoxyribonucleotide binding(GO:0032560) dGTP binding(GO:0032567) |
| 0.1 | 1.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.1 | 0.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.1 | 1.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.1 | 0.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.1 | 1.2 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.1 | 0.4 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.1 | 8.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 0.6 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.1 | 0.2 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.1 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.1 | 0.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.0 | 0.2 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.0 | 1.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) lipoprotein particle receptor binding(GO:0070325) |
| 0.0 | 0.6 | GO:0036122 | BMP binding(GO:0036122) |
| 0.0 | 1.8 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.0 | 1.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.0 | 50.2 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 0.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.0 | 0.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.0 | 1.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.0 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.0 | 1.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.0 | 0.2 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.0 | 0.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.0 | 0.3 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.0 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 0.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.0 | 0.2 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.0 | 2.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.0 | 0.2 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
| 0.0 | 0.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.0 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.0 | 1.6 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) aspartate-tRNA(Asn) ligase activity(GO:0050560) |
| 0.0 | 0.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.0 | 0.2 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 0.0 | 0.4 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.0 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.0 | 0.1 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.0 | 4.8 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.0 | 0.9 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.0 | 0.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.0 | 0.1 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 0.0 | 0.6 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.0 | 0.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.0 | 0.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.0 | 0.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.0 | 0.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.0 | 0.3 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.0 | 0.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.0 | 1.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.0 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.0 | 0.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.0 | 0.2 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.0 | 1.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.0 | 0.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.0 | 0.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 1.1 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.0 | 0.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.0 | 2.2 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
| 0.0 | 4.2 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.2 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
| 0.0 | 0.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.0 | 0.2 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.0 | 1.2 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.0 | 0.4 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
| 0.0 | 1.3 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.0 | 3.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.0 | 0.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.0 | 0.4 | GO:0048038 | quinone binding(GO:0048038) |
| 0.0 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 0.1 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 0.0 | 0.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.0 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.0 | 0.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.0 | 0.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.0 | 0.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.0 | 0.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.0 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.0 | 0.1 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.0 | 0.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.0 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.0 | 0.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.0 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.0 | 0.7 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
| 0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.0 | 0.1 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.0 | 0.2 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
| 0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 9.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.4 | 1.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.4 | 15.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.4 | 44.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.3 | 21.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.3 | 8.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.3 | 16.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.3 | 13.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.2 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.2 | 6.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.2 | 18.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.2 | 22.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.2 | 11.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.2 | 4.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.2 | 8.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.2 | 12.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.2 | 16.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.2 | 6.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 2.4 | PID EPO PATHWAY | EPO signaling pathway |
| 0.2 | 1.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.2 | 2.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.2 | 11.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.2 | 12.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 9.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 7.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 2.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.1 | 7.7 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 3.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.1 | 6.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 6.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 34.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 3.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 5.8 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.1 | 2.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.1 | 1.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.1 | 4.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.1 | 2.8 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.1 | 3.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.1 | 0.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 2.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.1 | 3.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.1 | 2.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 2.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 1.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 2.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.1 | 1.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 1.2 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.1 | 8.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 2.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.1 | 1.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 3.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.1 | 4.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 4.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.0 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.0 | 1.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.0 | 0.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.0 | 1.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 16.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 1.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 1.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 1.9 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.0 | 0.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.0 | 0.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.0 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.0 | 1.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 3.3 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.0 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 1.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 0.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.0 | 0.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 0.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 1.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 1.2 | PID P73PATHWAY | p73 transcription factor network |
| 0.0 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.0 | 0.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.0 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.0 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 2.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 1.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 1.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 91.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 1.3 | 9.0 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
| 1.2 | 32.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 1.0 | 24.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 1.0 | 17.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.7 | 16.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.6 | 6.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.5 | 17.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.4 | 16.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.4 | 13.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.3 | 15.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.3 | 1.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.3 | 6.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.3 | 6.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.3 | 6.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.3 | 5.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.3 | 4.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.3 | 17.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.3 | 0.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
| 0.2 | 4.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.2 | 7.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.2 | 9.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.2 | 11.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.2 | 3.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.2 | 7.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.2 | 6.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.2 | 9.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.2 | 7.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.2 | 5.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.2 | 3.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.2 | 18.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.2 | 1.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.2 | 5.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.2 | 7.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.2 | 3.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.2 | 2.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.2 | 3.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.2 | 5.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.2 | 4.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.2 | 8.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.2 | 4.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.2 | 2.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.2 | 4.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.2 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.2 | 4.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.2 | 5.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.2 | 8.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.2 | 2.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.2 | 4.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 2.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.1 | 3.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 2.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.1 | 5.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.1 | 1.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.1 | 11.7 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.1 | 4.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 2.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
| 0.1 | 13.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 3.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.1 | 4.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.1 | 11.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 15.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 2.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.1 | 6.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 2.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.1 | 4.1 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
| 0.1 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 3.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 0.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 6.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 2.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 11.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 1.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.1 | 2.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 2.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.1 | 0.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.1 | 2.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 1.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 0.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 0.3 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.1 | 6.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 4.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.1 | 4.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.1 | 2.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.1 | 13.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.1 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.1 | 2.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 2.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 1.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.1 | 2.4 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
| 0.1 | 2.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 1.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 3.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.1 | 2.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 1.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 1.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.1 | 2.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.1 | 1.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 1.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.1 | 1.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 0.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.1 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 1.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.1 | 0.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.1 | 3.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.1 | 1.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 1.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.0 | 0.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.0 | 3.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.0 | 1.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 2.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.0 | 2.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.0 | 0.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.0 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.0 | 0.8 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.0 | 2.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.0 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.0 | 0.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 1.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
| 0.0 | 0.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.0 | 4.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 3.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.0 | 3.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.0 | 2.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.0 | 0.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.0 | 5.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.0 | 1.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.0 | 0.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.0 | 1.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.0 | 1.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.0 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.0 | 0.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.0 | 0.8 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
| 0.0 | 5.5 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.0 | 2.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.0 | 4.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 0.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 2.7 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
| 0.0 | 0.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.0 | 0.8 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.0 | 0.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.0 | 0.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 0.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.0 | 1.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.0 | 0.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.0 | 0.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 0.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
| 0.0 | 0.0 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |